On the contrary, our results demonstrate that upregulation of SIRT3 was a risk factor for lymph node metastasis in breast cancer patients, which implicate the tumor promoter role of SIRT3 in advanced stages of breast cancer. Here, SIRT3 is linked to metastatic malignant neoplasm in the lymph nodes.